64 related articles for article (PubMed ID: 9738568)
1. Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma.
Sandor V; Stark-Vancs V; Pearson D; Nussenblat R; Whitcup SM; Brouwers P; Patronas N; Heiss J; Jaffe E; deSmet M; Kohler D; Simon R; Wittes R
J Clin Oncol; 1998 Sep; 16(9):3000-6. PubMed ID: 9738568
[TBL] [Abstract][Full Text] [Related]
2. Advantages of dose-dense methotrexate protocol for primary central nervous system lymphoma: comparison of two different protocols at a single institution.
Aoki H; Ogura R; Tsukamoto Y; Okada M; Natsumeda M; Isogawa M; Yoshida S; Fujii Y
Neurol Med Chir (Tokyo); 2013; 53(11):797-804. PubMed ID: 24162244
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of etoposide and cytarabine as consolidation in elderly patients with primary CNS lymphoma.
Kim YR; Cho H; Kim SJ; Chung H; Kook HW; Jang JE; Cheong JW; Kim JS
Oncologist; 2024 Jun; 29(6):e796-e802. PubMed ID: 38581718
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of the oldest patients with primary CNS lymphoma treated at Memorial Sloan-Kettering Cancer Center.
Welch MR; Omuro A; Deangelis LM
Neuro Oncol; 2012 Oct; 14(10):1304-11. PubMed ID: 22952196
[TBL] [Abstract][Full Text] [Related]
5. Case report: Rapid resolution of grade IV ICANS after first line intrathecal chemotherapy with methotrexate, cytarabine and dexamethasone.
Katsin M; Shman T; Migas A; Lutskovich D; Serada Y; Khalankova Y; Kostina Y; Dubovik S
Front Immunol; 2024; 15():1380451. PubMed ID: 38765003
[TBL] [Abstract][Full Text] [Related]
6. Nomograms Predict Survival Outcome of Primary Intramedullary Spinal Cord Lymphoma Patients.
Wu Q; Yang Z; Xu Y
Med Sci Monit; 2019 Oct; 25():7418-7429. PubMed ID: 31579048
[TBL] [Abstract][Full Text] [Related]
7. Advances in the treatment of newly diagnosed primary central nervous system lymphomas.
Qian L; Tomuleasa C; Florian IA; Shen J; Florian IS; Zdrenghea M; Dima D
Blood Res; 2017 Sep; 52(3):159-166. PubMed ID: 29043230
[TBL] [Abstract][Full Text] [Related]
8. Primary central nervous system lymphoma: essential points in diagnosis and management.
Paydas S
Med Oncol; 2017 Apr; 34(4):61. PubMed ID: 28315229
[TBL] [Abstract][Full Text] [Related]
9. [Special hematological diagnostics and therapy options for ocular lymphoma taking CNS involvement into account].
Korfel A; Schlegel U; Schroers R
Ophthalmologe; 2015 Mar; 112(3):231-6. PubMed ID: 25721677
[TBL] [Abstract][Full Text] [Related]
10. Pilot study of gamma-knife surgery-incorporated systemic chemotherapy omitting whole brain radiotherapy for the treatment of elderly primary central nervous system lymphoma patients with poor prognostic scores.
Cho J; Kim J; Ryu HJ; Roh HG; Chung HW; Koh YC; Lee MH; Ko YH; Kim SY
Med Oncol; 2014 Mar; 31(3):863. PubMed ID: 24496562
[TBL] [Abstract][Full Text] [Related]
11. High-dose methotrexate, high-dose cytarabine and temozolomide for the treatment of primary central nervous system lymphoma (PCNSL).
Salamoon M; Hussein T; Kenj M; Bachour M
Med Oncol; 2013 Dec; 30(4):690. PubMed ID: 23959450
[TBL] [Abstract][Full Text] [Related]
12. A case series of primary central nervous system posttransplantation lymphoproliferative disorder: imaging and clinical characteristics.
Lake W; Chang JE; Kennedy T; Morgan A; Salamat S; Başkaya MK
Neurosurgery; 2013 Jun; 72(6):960-70; discussion 970. PubMed ID: 23685504
[TBL] [Abstract][Full Text] [Related]
13. Management of elderly patients with primary central nervous system lymphoma.
Daras M; DeAngelis LM
Curr Neurol Neurosci Rep; 2013 May; 13(5):344. PubMed ID: 23564069
[TBL] [Abstract][Full Text] [Related]
14. Current and emerging pharmacotherapies for primary CNS lymphoma.
Prodduturi P; Bierman PJ
Clin Med Insights Oncol; 2012; 6():219-31. PubMed ID: 22654527
[TBL] [Abstract][Full Text] [Related]
15. The impact of chemotherapy on cognitive outcomes in adults with primary brain tumors.
Abrey LE
J Neurooncol; 2012 Jun; 108(2):285-90. PubMed ID: 22350376
[TBL] [Abstract][Full Text] [Related]
16. Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI.
Wieduwilt MJ; Valles F; Issa S; Behler CM; Hwang J; McDermott M; Treseler P; O'Brien J; Shuman MA; Cha S; Damon LE; Rubenstein JL
Clin Cancer Res; 2012 Feb; 18(4):1146-55. PubMed ID: 22228634
[TBL] [Abstract][Full Text] [Related]
17. Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium.
Chan CC; Rubenstein JL; Coupland SE; Davis JL; Harbour JW; Johnston PB; Cassoux N; Touitou V; Smith JR; Batchelor TT; Pulido JS
Oncologist; 2011; 16(11):1589-99. PubMed ID: 22045784
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy in newly diagnosed primary central nervous system lymphoma.
Hashemi-Sadraei N; Peereboom DM
Ther Adv Med Oncol; 2010 Jul; 2(4):273-92. PubMed ID: 21789140
[TBL] [Abstract][Full Text] [Related]
19. Primary intraocular lymphoma: a review.
Vosganian GS; Boisot S; Hartmann KI; Freeman WR; Sharpe RW; Tripuraneni P; Saven A
J Neurooncol; 2011 Nov; 105(2):127-34. PubMed ID: 21626069
[TBL] [Abstract][Full Text] [Related]
20. Primary CNS lymphoma in patients younger than 60: can whole-brain radiotherapy be deferred?
Omuro A; Taillandier L; Chinot O; Sierra Del Rio M; Carnin C; Barrie M; Soussain C; Tanguy ML; Choquet S; Leblond V; Hoang-Xuan K;
J Neurooncol; 2011 Aug; 104(1):323-30. PubMed ID: 21170569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
